Science & Research Staff Directory
CAMH is a leader in mental health research, with more than 120 scientists at the core of our research enterprise.
Meet Our Scientists
Dr. James L. Kennedy
Head, Molecular Science and Head, Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, CAMH
jim.kennedy@camh.ca Read more about Dr. James L. KennedyAkwatu Khenti
Scientist, Institute for Mental Health Policy Research, CAMH
akwatu.khenti@camh.ca Read more about Akwatu Khenti
Dr. Michael Kiang
Clinician Scientist, Temerty Centre for Therapeutic Brain Intervention and Psychiatrist, Schizophrenia Division, CAMH
michael.kiang@camh.ca Read more about Dr. Michael Kiang
Dr. Sean A. Kidd
Chief, Psychology Division, CAMH
sean.kidd@camh.ca Read more about Dr. Sean A. KiddDr. Stephen J. Kish
Senior Scientist and Head, Human Brain Laboratory, Research Imaging Centre, Campbell Family Mental Health Research Institute, CAMH
stephen.kish@camh.ca Read more about Dr. Stephen J. KishDr. Stefan Kloiber
Psychiatrist and Clinician Scientist, Mood and Anxiety Division and Campbell Family Mental Health Research Institute; Medical Head, Mood and Anxiety Ambulatory Services, CAMH
stefan.kloiber@camh.ca Read more about Dr. Stefan Kloiber
Dr. Nicole Kozloff
Child and Adolescent Psychiatrist and Clinician Scientist, Slaight Family Centre for Youth in Transition, Child, Youth and Emerging Adult Program, CAMH
nicole.kozloff@camh.ca Read more about Dr. Nicole Kozloff
Dr. Sanjeev Kumar
Clinician Scientist, Staff Psychiatrist and Medical Head, Geriatric Clinical Research, CAMH
sanjeev.kumar@camh.ca Read more about Dr. Sanjeev KumarDr. Paul Kurdyak
Director, Health Outcomes and Performance Evaluation, Institute for Mental Health Policy Research and Medical Director, Performance Improvement, CAMH
paul.kurdyak@camh.ca Read more about Dr. Paul Kurdyak
Dr. Meng-Chuan Lai
Clinician Scientist and O’Brien Scholar, Child and Youth Mental Health Collaborative, CAMH
meng-chuan.lai@camh.ca Read more about Dr. Meng-Chuan Lai
CAMH research leads to changes in care to mitigate impact of COVID-19 on those made vulnerable
Clinicians implement recommendations to mitigate the effects of COVID-19 on people with schizophrenia and those with Alzheimer’s.
Read More
Suicide rate for people with schizophrenia spectrum disorders 170 times higher than the general population
Study identifies key risk factors
Read More
CAMH celebrates the launch of womenmind™
New philanthropic program will focus on closing the gender gap in mental health
Read More
We can email you tips and tools to help you manage your mental health during COVID-19.
Read More